Teladoc Health Names Chuck Divita as CEO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises in broad rebound; yields push markets towards weekly declines
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
- SpaceX shares fall as second lockup period ends
BofA Securities Reiterates Neutral Rating on Teladoc (TDOC)
June 11, 2024 5:28 AM EDTBofA Securities analyst Allen Lutz reiterated a Neutral rating and $13.50 price target on Teladoc (NYSE: TDOC).
The analyst comments "Filling the CEO role will likely remove the overhang that has been driving investor questions on who will lead the company through the next phase of growth. Mr. Divita has broad experience driving growth and advancing new models... More
Citi Reiterates Neutral Rating on Teladoc (TDOC)
June 10, 2024 8:29 AM EDTCiti analyst Daniel Grosslight reiterated a Neutral rating and $15.50 price target on Teladoc (NYSE: TDOC).
The analyst comments "We had a chance to catch-up with TDOC mgmt this morning after the company announced Chuck Divita will be joining as CEO (LINK, 6/10). Chuck... More
